117 related articles for article (PubMed ID: 20020127)
1. The role of chemokines in B cell chronic lymphocytic leukaemia: pathophysiological aspects and clinical impact.
Schröttner P; Leick M; Burger M
Ann Hematol; 2010 May; 89(5):437-46. PubMed ID: 20020127
[TBL] [Abstract][Full Text] [Related]
2. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R
Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
[TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia: insights from lymph nodes & bone marrow and clinical perspectives.
Jaksić O; Kardum-Skelin I; Jaksić B
Coll Antropol; 2010 Mar; 34(1):309-13. PubMed ID: 20432765
[TBL] [Abstract][Full Text] [Related]
5. Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia.
Alfonso-Pérez M; López-Giral S; Quintana NE; Loscertales J; Martín-Jiménez P; Muñoz C
J Leukoc Biol; 2006 Jun; 79(6):1157-65. PubMed ID: 16603585
[TBL] [Abstract][Full Text] [Related]
6. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V
Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
8. High endothelial venules and cell adhesion molecules in B-cell chronic lymphocytic leukaemia and related low grade B-cell lymphoma/leukaemia: I. High endothelial venules and lymphocyte migration.
Csanaky G
Histol Histopathol; 1994 Jul; 9(3):571-5. PubMed ID: 7981503
[TBL] [Abstract][Full Text] [Related]
9. High endothelial venules and cell adhesion molecules in B-cell chronic lymphocytic leukaemia and related low grade B-cell lymphoma/leukaemia: II. Expression of cell adhesion molecules in lymph nodes biopsies.
Csanaky G
Histol Histopathol; 1994 Jul; 9(3):577-82. PubMed ID: 7526911
[TBL] [Abstract][Full Text] [Related]
10. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
[TBL] [Abstract][Full Text] [Related]
11. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J
Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771
[TBL] [Abstract][Full Text] [Related]
12. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia.
Shanafelt TD; Kay NE
Semin Oncol; 2006 Apr; 33(2):174-85. PubMed ID: 16616064
[TBL] [Abstract][Full Text] [Related]
13. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G
Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639
[TBL] [Abstract][Full Text] [Related]
14. Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23.
Chen JR; Gu BJ; Dao LP; Bradley CJ; Mulligan SP; Wiley JS
Br J Haematol; 1999 Apr; 105(1):181-9. PubMed ID: 10233382
[TBL] [Abstract][Full Text] [Related]
15. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
Ebert LM; Schaerli P; Moser B
Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268
[TBL] [Abstract][Full Text] [Related]
16. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation.
Ghia P; Chiorazzi N; Stamatopoulos K
J Intern Med; 2008 Dec; 264(6):549-62. PubMed ID: 19017179
[TBL] [Abstract][Full Text] [Related]
17. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
18. HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.
Rebmann V; Nückel H; Dührsen U; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):430-5. PubMed ID: 17683947
[TBL] [Abstract][Full Text] [Related]
19. Intracellular IFN-gamma expression by CD3+/CD8+ cell subset in B-CLL patients correlates with stage of the disease.
Podhorecka M; Dmoszynska A; Rolinski J
Eur J Haematol; 2004 Jul; 73(1):29-35. PubMed ID: 15182335
[TBL] [Abstract][Full Text] [Related]
20. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
